AJANTA PHARMA LTD. - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
16 May 2022
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 16, 2022 for Ravi Agrawal, trustee Ravi Agrawal Trust
Source:
BSE India